ResultsIQ

ResultsIQ › Latest results › Park Medi World Limited

Park Medi World Limited Q2 FY27 results press release summary

NSE: PARKHOSPS · BSE: 544645

Results press release of 13 Nov 2026, summarised by AI from the filing.

680 beds added in six months through Rudrapur and Panchkula, taking capacity to 4,290 beds.

Key takeaways

  1. New beds 680 beds added in six months through Rudrapur and Panchkula, taking capacity to 4,290 beds.
  2. Ramp-up risk New capacity has had a near-term bearing on occupancy and profitability as facilities take time to ramp up.

Original filing on BSE

Park Medi World Limited Q2 FY27 results

As filed: Revenue ₹511 cr, EBITDA ₹102 cr, PAT ₹54.5 cr, EBITDA margin 19.9%.

Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹511 cr). Scored once a year-earlier consolidated quarter exists.

Earlier results and the share price after them

  • Q1 FY27: Revenue ₹476 cr, EBITDA ₹126 cr, PAT ₹88.6 cr, EBITDA margin 26.5%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹476 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: −5.4% in 30 days (Nifty 500: −1.0%).
  • Q4 FY26: Revenue ₹460 cr, EBITDA ₹127 cr, PAT ₹76.8 cr, EBITDA margin 27.7%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹460 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +5.2% in 30 days (Nifty 500: −3.0%).
  • Q3 FY26: Revenue ₹410 cr, EBITDA ₹99.4 cr, PAT ₹52.9 cr, EBITDA margin 24.3%. Not scored. No consolidated results for the same quarter last year to compare yet (consolidated revenue ₹410 cr). Scored once a year-earlier consolidated quarter exists. Share price after the results: +29.5% in 30 days (Nifty 500: +1.5%).

Past price moves after results do not indicate future moves. Not a recommendation.

Park Medi World Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.